Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 31733926 | HLA-DPB1 (HLA-DPB1) | stem cell transplantation | Chinese | NA | NA | unclassified | |
| due to the hardy-weinberg equilibrium proportions (hwep) deviation in dpb1 loci, this information may be of limited use for phylogenetic, comparative studies but will be useful for the permissible matching in hla-dpb1 for chinese patients awaiting haematopoietic stem cell transplantation in the near future due to the new recommendation of nmdp matching guidelines. | |||||||
| 31801701 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| immunological life-threatening complications frequently occur in post-hematopoietic stem cell transplantation (hsct), despite matching recipient and donor (r/d) pairs for classical human leukocyte antigens (hla). | |||||||
| 31801701 | MHC (MHC) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| investigation of mhc gamma block c4a and c4b polymorphisms in unrelated hematopoietic stem cell transplantation. | |||||||
| 31832060 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| hla matching in pediatric stem cell transplantation. | |||||||
| 31832062 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| predicted indirectly recognizable hla epitopes (pirche) are associated with poorer outcome after single mismatch unrelated donor stem cell transplantation: a study of the cooperative transplant study group (kts) of the german group for bone marrow and stem cell transplantation (dag-kbt). | |||||||
| 31832062 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| we performed a multicenter retrospective study evaluating the impact pirche on outcome after allogeneic stem cell transplantation (allo-hsct) from single mismatched (hla 9/10 matched) unrelated donors. | |||||||
| 32019730 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| prophylactic dli was given at 30 days after transplantation in patients who received human leukocyte antigen (hla)-matched related human stem cell transplantation (hsct) or 45 to 60 days post-transplant in patients receiving haploidentical hsct or hla-matched unrelated hsct. | |||||||
| 32224144 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | methotrexate | NA | melphalan | NA | unclassified | |
| NA | |||||||
| 32385341 | HLA MISMATCHED (HLA-MISMATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| rituximab for desensitization during hla-mismatched stem cell transplantation in patients with a positive donor-specific anti-hla antibody. | |||||||
| 32461586 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| interrogating the impact of kir ligand mismatch in engraftment following hla-disparate stem cell transplantation. | |||||||
Copyright 2024